Literature DB >> 14219941

IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.

J A KASEL, M HUBER, F LODA, P A BANKS, V KNIGHT.   

Abstract

Entities:  

Keywords:  ADENOVIRUS INFECTIONS; ANTIBODY FORMATION; IMMUNIZATION; NEUTRALIZATION TESTS; VIRAL VACCINES

Mesh：

Substances：

Year:  1964        PMID： 14219941     DOI： 10.3181/00379727-117-29531

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  6 in total

1.  Potency of adenovirus vaccines: comparison of unconcentrated, concentrated, and soluble antigen preparations.

Authors:  R R Strauss; N R Goulet; O C Liu; J M Beiler
Journal:  Appl Microbiol       Date:  1966-11

2.  Specific humoral immunity among volunteers with experimental adenovirus infection.

Authors:  A A Selivanov; T P Kovaleva; A A Smorodintsev
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  Homotypic and heterotypic antibody response in infants to adenovirus vaccine.

Authors:  J van der Veen; D J van Zaane; M A Sprangers; C F Heyen
Journal:  Arch Gesamte Virusforsch       Date:  1967

4.  Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.

Authors:  W J Kramp; H R Six; S Drake; J A Kasel
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

6.  Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.

Authors:  Cheng Cheng; Lingshu Wang; LingShu Wang; Jason G D Gall; Martha Nason; Richard M Schwartz; M Juliana McElrath; Steven C DeRosa; John Hural; Lawrence Corey; Susan P Buchbinder; Gary J Nabel
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.